IMMUNOPRECISE ANTIBODIES LTD. Chart calendar ImmunoPrecise Antibodies Ltd.
06b44b295d2.Khv8k9gBOqvLPPV3ZTASuL0Ghf8vZQBoPsjQFAPfoHE.TniN8JN4W8WpSodHMwF1y9Vk3LxKHDMsSo66UlWuwQYHbZHG6DVU5JpXkg~f206c7e25ab0ada481eac58b6835a896
Upcoming events on ImmunoPrecise Antibodies Ltd.
Past events on ImmunoPrecise Antibodies Ltd.
| 14/03/2024 14:30 | Q3 2024 Earnings Call |
| 14/03/2024 11:56 | Q3 2024 Earnings Release |
| 14/12/2023 15:30 | Q2 2024 Earnings Call |
| 14/12/2023 13:01 | Q2 2024 Earnings Release |
| 09/11/2023 18:00 | Annual General Meeting |
| 14/09/2023 15:30 | Q1 2024 Earnings Call |
| 14/09/2023 13:00 | Q1 2024 Earnings Release |
| 19/07/2023 21:00 | Business Update Call |
| 07/07/2023 15:30 | Q4 2023 Earnings Call |
| 07/07/2023 13:10 | Q4 2023 Earnings Release |
| 09/06/2023 16:00 | Jefferies Global Healthcare Conference |
| 17/04/2023 14:00 | American Association for Cancer Research Meeting - Poster Number 29 |
| 16/03/2023 14:30 | Q3 2023 Earnings Call |
| 16/03/2023 12:00 | Q3 2023 Earnings Release |
| 15/12/2022 15:30 | Interim 2023 Earnings Call |
| 15/12/2022 13:03 | Interim 2023 Earnings Release |
| 13/12/2022 14:30 | Annual General Meeting |
| 14/09/2022 15:30 | Q1 2023 Earnings Call |
| 14/09/2022 13:04 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 10,9 11,7 -6.61% | 14,1 14,0 0.37% | 0,00 | 19,4 19,1 1.44% | 20,7 20,8 -0.41% | 24,6 |
|
EBITDA Million CAD | Released Forecast Spread | -3,90 -1,70 -129.34% | 0,05 0,10 -47.81% | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 0,00 - | -4,55 -3,28 -38.95% | 0,00 | -16,7 -16,3 -2.87% | -28,6 -26,8 -6.45% | -13,8 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 0,00 - | -5,29 -4,10 -29.16% | 0,00 | -15,8 -15,1 -4.96% | -27,8 -26,4 -5.3% | -13,1 |
|
Net income Million CAD | Released Forecast Spread | 0,00 0,00 - | -4,95 -4,29 -15.29% | -7,34 | -16,7 -15,9 -5.13% | -26,6 -26,0 -2.03% | -12,1 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | -0,81 -0,77 -4.84% | -0,35 |
| Announcement Date | 28/08/19 | 28/08/20 | 28/07/21 | 29/07/22 | 10/07/23 | - |
Quarterly results
| Fiscal Period | April | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 4,82 5,00 -3.7% | 5,20 5,00 4% | 4,70 5,30 -11.32% | 5,20 5,08 2.34% | 5,17 5,43 -4.83% | 5,62 5,71 -1.49% | 5,69 5,35 6.32% | 6,15 5,85 5.08% | 6,22 6,07 2.52% | 6,53 | 6,80 | 7,40 | 7,50 | 8,10 |
|
EBIT Million CAD | Released Forecast Spread | -4,31 -4,69 8.17% | -4,29 -3,82 -12.23% | -10,1 -3,61 -179% | -7,82 -4,25 -84.01% | -4,58 -5,96 23.19% | -6,08 -4,35 -39.81% | -4,18 -5,10 18.1% | -3,02 -3,50 13.52% | -3,34 -2,80 -19.14% | -3,30 | ||||
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -3,62 -4,59 21.18% | -4,37 -3,62 -20.69% | -9,78 -3,31 -195.59% | -7,48 -3,66 -104.29% | -4,60 -7,59 39.46% | -5,90 -4,50 -31.04% | -3,83 -4,90 21.9% | -2,59 -3,70 30% | -3,46 -2,65 -30.28% | -3,25 | ||||
|
Net income Million CAD | Released Forecast Spread | -3,83 -4,79 20.13% | -4,64 -3,82 -21.57% | -9,40 -3,41 -175.66% | -7,35 -3,41 -115.57% | -4,70 -7,44 36.84% | -5,13 -4,60 -11.52% | -3,57 -4,80 25.73% | -2,62 -3,50 25.09% | -2,94 -2,67 -10.17% | -3,00 | ||||
|
EPS USD | Released Forecast Spread | -0,22 | -0,14 -0,22 37.2% | -0,15 -0,13 -14.02% | -0,10 -0,14 27.65% | -0,07 -0,10 29.14% | -0,08 -0,08 -8.51% | -0,09 | -0,07 | -0,04 | -0,06 | -0,07 | |||
| Announcement Date | 16/03/22 | 29/07/22 | 14/09/22 | 15/12/22 | 16/03/23 | 10/07/23 | 14/09/23 | 14/12/23 | 14/03/24 | - | - | - | - | - |
| Today 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 06/05/2024 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
